Cardiac Recovery During Long-Term Left Ventricular Assist Device Support.

[1]  Robert L Kormos,et al.  Seventh INTERMACS annual report: 15,000 patients and counting. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[2]  L. Lund,et al.  The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Heart Transplantation Report--2015; Focus Theme: Early Graft Failure. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  M. Walsh,et al.  Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee. , 2015, Journal of cardiac failure.

[4]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.

[5]  M. Slaughter,et al.  Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support). , 2014, Journal of the American College of Cardiology.

[6]  Miyoko Endo,et al.  Preoperative beta-blocker treatment is a key for deciding left ventricular assist device implantation strategy as a bridge to recovery , 2014, Journal of Artificial Organs.

[7]  Elisa F. Long,et al.  Comparative Survival and Cost-Effectiveness of Advanced Therapies for End-Stage Heart Failure , 2014, Circulation. Heart failure.

[8]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[9]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[10]  Igor Gregoric,et al.  HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[11]  E. Adler,et al.  Functional improvement after ventricular assist device implantation: is ventricular recovery more common than we thought? , 2013, Journal of the American College of Cardiology.

[12]  Gregory J. Stoddard,et al.  Pulsatility and the Risk of Nonsurgical Bleeding in Patients Supported With the Continuous-Flow Left Ventricular Assist Device HeartMate II , 2013, Circulation. Heart failure.

[13]  Dean Y. Li,et al.  Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery. , 2013, Journal of the American College of Cardiology.

[14]  Snehal R. Patel,et al.  Combining neurohormonal blockade with continuous-flow left ventricular assist device support for myocardial recovery: a single-arm prospective study. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[15]  N. Smedira,et al.  Unplanned hospital readmissions after HeartMate II implantation: frequency, risk factors, and impact on resource use and survival. , 2013, JACC. Heart failure.

[16]  Yariv N. Marmor,et al.  Readmissions after implantation of axial flow left ventricular assist device. , 2013, Journal of the American College of Cardiology.

[17]  Dean Y. Li,et al.  Morbidity and Mortality in Heart Transplant Candidates Supported With Mechanical Circulatory Support: Is Reappraisal of the Current United Network for Organ Sharing Thoracic Organ Allocation Policy Justified? , 2012, Circulation.

[18]  D. Burkhoff,et al.  Myocardial recovery and the failing heart: myth, magic, or molecular target? , 2012, Journal of the American College of Cardiology.

[19]  Dean Y. Li,et al.  Bridge to Recovery: Understanding the Disconnect Between Clinical and Biological Outcomes , 2012, Circulation.

[20]  A. Khaghani,et al.  Long-term outcomes of patients bridged to recovery versus patients bridged to transplantation. , 2012, The Journal of thoracic and cardiovascular surgery.

[21]  D. Farrar,et al.  Young patients with nonischemic cardiomyopathy have higher likelihood of left ventricular recovery during left ventricular assist device support. , 2012, Journal of cardiac failure.

[22]  Magdi H. Yacoub,et al.  Reversal of Severe Heart Failure With a Continuous-Flow Left Ventricular Assist Device and Pharmacological Therapy: A Prospective Study , 2011, Circulation.

[23]  Roland Hetzer,et al.  Heart failure reversal by ventricular unloading in patients with chronic cardiomyopathy: criteria for weaning from ventricular assist devices , 2010, European heart journal.

[24]  S. Russell,et al.  Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. , 2010, Journal of the American College of Cardiology.

[25]  J. Gorcsan,et al.  Left ventricular remodeling and myocardial recovery on mechanical circulatory support. , 2010, Journal of cardiac failure.

[26]  S. Russell,et al.  Advanced heart failure treated with continuous-flow left ventricular assist device. , 2009, The New England journal of medicine.

[27]  C. O'connor,et al.  Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries. , 2008, JAMA.

[28]  Karen Ulisney,et al.  INTERMACS database for durable devices for circulatory support: first annual report. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[29]  R. Hetzer,et al.  Prediction of Cardiac Stability After Weaning From Left Ventricular Assist Devices in Patients With Idiopathic Dilated Cardiomyopathy , 2008, Circulation.

[30]  O H Frazier,et al.  Use of a continuous-flow device in patients awaiting heart transplantation. , 2007, The New England journal of medicine.

[31]  O H Frazier,et al.  Cardiac Improvement During Mechanical Circulatory Support: A Prospective Multicenter Study of the LVAD Working Group , 2007, Circulation.

[32]  K. Karason,et al.  The feasibility of left ventricular mechanical support as a bridge to cardiac recovery , 2007, European journal of heart failure.

[33]  M. Yacoub,et al.  Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy. , 2006, European heart journal.

[34]  Magdi H Yacoub,et al.  Left ventricular assist device and drug therapy for the reversal of heart failure. , 2006, The New England journal of medicine.

[35]  R. Hetzer,et al.  Long-Term Results in Patients With Idiopathic Dilated Cardiomyopathy After Weaning From Left Ventricular Assist Devices , 2005, Circulation.

[36]  S. Raj,et al.  Letter regarding article by Adamson et al, "Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device". , 2005, Circulation.

[37]  Douglas L Mann,et al.  Mechanisms and models in heart failure: the biomechanical model and beyond. , 2005, Circulation.

[38]  A. Khaghani,et al.  Clinical Recovery From End-Stage Heart Failure Using Left-Ventricular Assist Device and Pharmacological Therapy Correlates With Increased Sarcoplasmic Reticulum Calcium Content but Not With Regression of Cellular Hypertrophy , 2004, Circulation.

[39]  A. Katz,et al.  Maladaptive Growth in the Failing Heart: The Cardiomyopathy of Overload , 2002, Cardiovascular Drugs and Therapy.

[40]  Robert L Kormos,et al.  Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[41]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[42]  M Flannery,et al.  Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. , 1998, Circulation.

[43]  C. Selzman,et al.  Bridge to removal: a paradigm shift for left ventricular assist device therapy. , 2015, The Annals of thoracic surgery.

[44]  G. Ewald,et al.  Unexpected abrupt increase in left ventricular assist device thrombosis. , 2014, The New England journal of medicine.

[45]  M. Yacoub,et al.  Bridge to recovery and weaning protocols. , 2014, Heart failure clinics.

[46]  R. Gray.  A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .